Hypogonadism and Cardiometabolic Disease: Defining the Relationship
Click on one of titles below to view presentations originally presented during the successful TU symposium held in conjunction with the American College of Physicians annual meeting, Internal Medicine 2012, in New Orleans.
Hypogonadism as a Prognosticator of Cardiovascular Disease:
Evaluating the Need for Screening, Diagnosis, and Referral
Martin M. Miner, MD
Director, Men’s Health Center
Miriam Hospital
Clinical Associate Professor of Family Medicine and Urology
Warren Alpert Medical School of Brown University
Providence, Rhode Island
Safely Managing Hypogonadism and Concomitant
Cardiometabolic Conditions
Adrian S. Dobs, MD, MHS
Professor of Medicine and Oncology
Johns Hopkins University School of Medicine
Division of Endocrinology and Metabolism
Baltimore, Maryland
Optimizing Hypogonadism Management:
Importance of Adherence to Therapy
Wayne J.G. Hellstrom, MD (Activity Chairperson)
Professor of Urology
Chief, Section of Andrology
Tulane University Medical Center
New Orleans, Louisiana
Evaluating the Need for Screening, Diagnosis, and Referral
Martin M. Miner, MD
Director, Men’s Health Center
Miriam Hospital
Clinical Associate Professor of Family Medicine and Urology
Warren Alpert Medical School of Brown University
Providence, Rhode Island
Cardiometabolic Conditions
Adrian S. Dobs, MD, MHS
Professor of Medicine and Oncology
Johns Hopkins University School of Medicine
Division of Endocrinology and Metabolism
Baltimore, Maryland
Importance of Adherence to Therapy
Wayne J.G. Hellstrom, MD (Activity Chairperson)
Professor of Urology
Chief, Section of Andrology
Tulane University Medical Center
New Orleans, Louisiana
This symposium was not part of the official Internal Medicine 2012 Educational Program.
Jointly sponsored by the Annenberg Center for Health Sciences at Eisenhower and CogniMed Inc.
This activity is supported by an independent educational grant provided by Abbott Laboratories and Lilly USA, LLC.
